期刊文献+

基于气相色谱-质谱联用技术的痛风病人血清代谢特征分析 被引量:8

Analysis of Serum Metabolic Characteristics in Patients with Gout Using Gas Chromatography-Mass Spectrometry
下载PDF
导出
摘要 痛风是一组仅见于人类的异质性疾病,随着时间的推移,将导致慢性关节炎并逐渐致残。该研究将基于气相色谱-质谱联用技术(GC-MS)的代谢组学方法应用于痛风病人的血清代谢特征分析。首先利用GCMS获得痛风病人和健康人的血清代谢指纹图谱,采用多变量统计分析对所得数据进行分析。主成分分析(PCA)得分图显示,痛风病人与健康人的血清代谢谱有差异。通过偏最小二乘-判别分析(PLS-DA)对样品进行进一步分型,根据模型的变量重要性因子(VIP值)及非参数检验结果筛选差异代谢物。共筛选出43种可能与痛风相关的代谢物,并对其中22个变量进行结构鉴定,主要包括丙二醇、2,3-二羟基丁酸、2,4-二羟基丁酸、赤藓糖醇、苏糖醇、苏糖酸、阿拉伯糖醇、D-葡萄糖酸、肌醇、次黄嘌呤、尿酸、尿苷、3-羟基-3-甲基丁酸、鸟氨酸、吲哚-3-乳酸、单乙醇胺、甘油、甘油酸、月桂酸及亚油酸等代谢物。与健康人相比,痛风病人的糖代谢、核苷酸代谢、氨基酸代谢及脂类代谢均发生了明显的紊乱。这些结果将为痛风临床诊断及治疗提供重要依据。 Gout is a highly heterogeneous disease which occurs only in human being,it would cause gouty arthritis,and even lead to disability. There could be obvious alterations of metabolites in the serum of the patient with gout,and the discovery of metabolic characteristics may be helpful for the clinical diagnosis and treatment of gout. A gas chromatography- mass spectrometry( GC- MS) based metabolic profiling method was employed to analyze the distinctive metabolic patterns of serum in gout patients. Serum samples collected from 29 gout patients and 26 healthy controls were analyzed. The principal component analysis( PCA) and partial least squares discriminant analysis( PLS- DA) were used to assess the metabolic data. Marked differences between gout patients and healthy controls were shown in PCA score plot. Variable importance for project values( VIP) and Student's t-test were combined to pick out the significant metabolic changes. Compared with that of the control group,the serum metabolic characteristics of the gout group were featured by increased levels of metabolites related to nucleotide metabolism( hypoxanthine,uric acid and uridine),carbohydrate metabolism( 2,3-dihydroxybutyrate,D-threitol,D-gluconic acid,myo-inositol,etc.) and amino acid metabolism( 3-hydroxy-3-methylbutyrate,L-ornithine and indole-3-lactic acid),decreased levels of lipids( monoethanolamine,glycerol,glyceric acid, etc.), glycine and hypotaurine. The preliminary results suggest that GC- MS based metabolic profiling method appears to be a useful tool in the exploration of the serum metabolic characteristics of gout. These revealed disease-associated metabolic perturbations involved in multiple metabolic pathways including purine metabolism and the urea cycle,which could help to elucidate the pathogenesis of gout and provide a potential aid for the accurate diagnosis or treatment of gout.
出处 《分析测试学报》 CAS CSCD 北大核心 2016年第2期137-142,共6页 Journal of Instrumental Analysis
基金 浙江省科技厅计划项目-分析测试科技计划项目(2015C37045) 国家自然科学基金青年科学基金项目(81403269) 国家重点基础研究发展计划资助项目973计划(2014CB543001)
关键词 痛风 代谢组学 气相色谱-质谱联用 血清 gout metabolomics gas chromatography-mass spectrometry(GC-MS) serum
  • 相关文献

参考文献29

  • 1Robinson PC, Dalbeth N. Expert. Opin. Pharmacother, 2015, 16 ( 4 ): 533 - 546.
  • 2Sarawate C A, Patel P A, Schumacher H R, Yang W Y, Brewer K K, Bakst A W.]. Clin. Rheumatol. , 2006, 12 (2): 61 - 65.
  • 3Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, N uki G. Ann Rheum Dis., 2008, 67 ( 7): 960 - 966.
  • 4Crittenden DB, Pillinger M H. Annu. Rev. Med. , 2013, 64: 325 - 337.
  • 5Mikuls T R, Saag K G. Curro Opin. Rheumatol. , 2006, 18 (2): 199 - 203.
  • 6Wallace S L, Robinson H, Masi AT, Decker J L, McCarty D J, Yu T F. Arthritis Rheum. , 1977, 20 ( 3 ): 895 - 900.
  • 7Guggi V, Calame L, Gerster J C. Joint Bone Spine, 2002, 69( 1): 58 - 61.
  • 8Bardin T, Richette P. Curro Opin. Rheumatol. , 2014, 26 (2): 186 - 191.
  • 9Harrold L R, Mazor K M, Negron A, Ogarek J, Firneno C, Y ood R A. Rheumatology ( Oxford), 2013, 52 ( 9 ) : 1623 -1629.
  • 10Madsen R, Lundstedt T, Trygg J. Anal. Chim. Acta, 2010, 659 ( 1/2): 23 - 33.

二级参考文献66

  • 1Brandwein-Gensler M,Teixeira M S,Lewis C M,et al.Am JSurg Pathol,2005,29(2):167.
  • 2Chen J,Wang W Z,Lv S,et al.Anal Chim Acta,2009,650(1):3.
  • 3Gao P,Lu C,Zhang F X,et al.Analyst,2008,133(9):1214.
  • 4Zhou J L,Xu B,Huang J,et al.Clin Chim Acta,2009,401(1/2):8.
  • 5Tiziani S,Lopes V,Günther U L.Neoplasia,2009,11(3):269.
  • 6Yan S K,Wei B J,Lin Z Y,et al.Oral Oncol,2008,44(5):477.
  • 7Sugimoto M,Wong D T,Hirayama A,et al.Metabolomics,2010,6(1):78.
  • 8Navazesh M.Ann NY Acad Sci,1993,694(1):72.
  • 9Smilde A K,van der Werf M J,Bijlsma S,et al.Anal Chem,2005,77(20):6729.
  • 10Bruce S J,Tavazzi I,Parisod V,et al.Anal Chem,2009,81(9):3285.

共引文献58

同被引文献94

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部